- Previous Close
3.4900 - Open
3.4600 - Bid 3.4500 x --
- Ask 3.5700 x --
- Day's Range
3.3800 - 3.4950 - 52 Week Range
3.3450 - 6.7400 - Volume
550,007 - Avg. Volume
617,571 - Market Cap (intraday)
830.406M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1300 - Earnings Date Feb 21, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.68
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. The company operates in three segments: Silex Systems, Translucent, and Silex USA. The company sells its cREO technology; and develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.
www.silex.com.auRecent News: SLX.AX
View MorePerformance Overview: SLX.AX
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SLX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SLX.AX
View MoreValuation Measures
Market Cap
825.65M
Enterprise Value
732.08M
Trailing P/E
--
Forward P/E
384.62
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
108.85
Price/Book (mrq)
7.20
Enterprise Value/Revenue
96.92
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-201.83%
Return on Assets (ttm)
-2.80%
Return on Equity (ttm)
-24.07%
Revenue (ttm)
15.18M
Net Income Avi to Common (ttm)
-30.63M
Diluted EPS (ttm)
-0.1300
Balance Sheet and Cash Flow
Total Cash (mrq)
94.59M
Total Debt/Equity (mrq)
0.89%
Levered Free Cash Flow (ttm)
-2.86M